English
简体中文
Total: £ 56.28
2025-05-02 | Pages: 87 | Tables: 87
The global market for Mitomycin C was valued at US$ 101 million in the year 2024 and is projected to reach a revised size of US$ 87 million by 2031, growing at a CAGR of -2.2% during the forecast period.Mitomycin C market, Mitomycin C is an antibioti...
2025-05-02 | Pages: 93 | Tables: 89
The global market for Resveratrol was valued at US$ 84.1 million in the year 2024 and is projected to reach a revised size of US$ 151 million by 2031, growing at a CAGR of 8.9% during the forecast period.Resveratrol is a stilbenoid, a type of natural...
2025-05-02 | Pages: 86 | Tables: 87
The global market for Bone Allograft and Xenograft was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.A bone graft is a surgical procedure used ...
2025-05-02 | Pages: 110 | Tables: 107
The global market for Wound Care Biologics was valued at US$ 4821 million in the year 2024 and is projected to reach a revised size of US$ 9726 million by 2031, growing at a CAGR of 10.7% during the forecast period.Wound Care Biologics is an evolving...
2025-05-02 | Pages: 80 | Tables: 86
The global market for Vegetable (HPMC) Capsule was valued at US$ 601 million in the year 2024 and is projected to reach a revised size of US$ 1010 million by 2031, growing at a CAGR of 7.8% during the forecast period.Hydroxypropyl methylcellulose is ...
2025-05-02 | Pages: 83 | Tables: 86
The global market for Enteric Empty Capsules was valued at US$ 94.8 million in the year 2024 and is projected to reach a revised size of US$ 260 million by 2031, growing at a CAGR of 15.7% during the forecast period.Enteric Empty Capsules is a niche ...
2025-05-02 | Pages: 83 | Tables: 78
The global market for Epidermal Growth Factor was valued at US$ 75.9 million in the year 2024 and is projected to reach a revised size of US$ 117 million by 2031, growing at a CAGR of 6.5% during the forecast period.Epidermal Growth Factor (EGF) is a...
2025-05-02 | Pages: 98 | Tables: 95
The global market for Dental Drug was valued at US$ 6015 million in the year 2024 and is projected to reach a revised size of US$ 8818 million by 2031, growing at a CAGR of 5.7% during the forecast period.There are a number of different drugs that de...
2025-05-02 | Pages: 91 | Tables: 93
The global market for Procalcitonin Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.Procalcitonin (PCT) is a 116 amino acid residue ...
2025-05-02 | Pages: 100 | Tables: 102
The global market for Antibody was valued at US$ 10070 million in the year 2024 and is projected to reach a revised size of US$ 14390 million by 2031, growing at a CAGR of 5.3% during the forecast period.Monoclonal Antibodies (IgMs) are antibodies th...
2025-05-02 | Pages: 75 | Tables: 75
The global market for Enzymatic Debridement was valued at US$ 304 million in the year 2024 and is projected to reach a revised size of US$ 517 million by 2031, growing at a CAGR of 8.0% during the forecast period.Enzymatic Debridement uses chemical e...
2025-05-02 | Pages: 111 | Tables: 112
The global market for Anthrax Vaccines was valued at US$ 758 million in the year 2024 and is projected to reach a revised size of US$ 1256 million by 2031, growing at a CAGR of 7.6% during the forecast period.Anthrax is a serious disease that can aff...
2025-05-02 | Pages: 95 | Tables: 88
The global market for Platinum based Cancer Drug was valued at US$ 1626 million in the year 2024 and is projected to reach a revised size of US$ 1954 million by 2031, growing at a CAGR of 2.7% during the forecast period.Platinum-based antineoplastic ...
2025-05-02 | Pages: 99 | Tables: 104
The global market for Life Science Reagents was valued at US$ 45540 million in the year 2024 and is projected to reach a revised size of US$ 76970 million by 2031, growing at a CAGR of 7.9% during the forecast period.Life science reagents means the r...
2025-05-02 | Pages: 81 | Tables: 84
The global market for IGY Polyclonal Antibodies was valued at US$ 8.6 million in the year 2024 and is projected to reach a revised size of US$ 17.8 million by 2031, growing at a CAGR of 11.1% during the forecast period.Immunoglobulin Y (abbreviated a...
